Cargando…

Barriers to effective treatment of vaginal atrophy with local estrogen therapy

Vaginal atrophy is a common condition among postmenopausal women, among whom many exhibit both vulvovaginal symptoms (eg, dryness, irritation, itching, and pain with intercourse) and urinary symptoms (eg, increased frequency, urgency, incontinence, urinary tract infections, and dysuria). Unfortunate...

Descripción completa

Detalles Bibliográficos
Autor principal: Reiter, Suzanne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3603331/
https://www.ncbi.nlm.nih.gov/pubmed/23525842
http://dx.doi.org/10.2147/IJGM.S43192
_version_ 1782263671746985984
author Reiter, Suzanne
author_facet Reiter, Suzanne
author_sort Reiter, Suzanne
collection PubMed
description Vaginal atrophy is a common condition among postmenopausal women, among whom many exhibit both vulvovaginal symptoms (eg, dryness, irritation, itching, and pain with intercourse) and urinary symptoms (eg, increased frequency, urgency, incontinence, urinary tract infections, and dysuria). Unfortunately, few women with symptoms of vaginal atrophy report seeking treatment from a health care provider. The goal of this article is to examine reasons why patients and health care providers do not engage in discourse regarding this important topic. It is important to initiate conversations with postmenopausal women and counsel them on both why the changes occur and potential treatment options.
format Online
Article
Text
id pubmed-3603331
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-36033312013-03-22 Barriers to effective treatment of vaginal atrophy with local estrogen therapy Reiter, Suzanne Int J Gen Med Review Vaginal atrophy is a common condition among postmenopausal women, among whom many exhibit both vulvovaginal symptoms (eg, dryness, irritation, itching, and pain with intercourse) and urinary symptoms (eg, increased frequency, urgency, incontinence, urinary tract infections, and dysuria). Unfortunately, few women with symptoms of vaginal atrophy report seeking treatment from a health care provider. The goal of this article is to examine reasons why patients and health care providers do not engage in discourse regarding this important topic. It is important to initiate conversations with postmenopausal women and counsel them on both why the changes occur and potential treatment options. Dove Medical Press 2013-03-15 /pmc/articles/PMC3603331/ /pubmed/23525842 http://dx.doi.org/10.2147/IJGM.S43192 Text en © 2013 Reiter, publisher and licensee Dove Medical Press Ltd. This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited.
spellingShingle Review
Reiter, Suzanne
Barriers to effective treatment of vaginal atrophy with local estrogen therapy
title Barriers to effective treatment of vaginal atrophy with local estrogen therapy
title_full Barriers to effective treatment of vaginal atrophy with local estrogen therapy
title_fullStr Barriers to effective treatment of vaginal atrophy with local estrogen therapy
title_full_unstemmed Barriers to effective treatment of vaginal atrophy with local estrogen therapy
title_short Barriers to effective treatment of vaginal atrophy with local estrogen therapy
title_sort barriers to effective treatment of vaginal atrophy with local estrogen therapy
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3603331/
https://www.ncbi.nlm.nih.gov/pubmed/23525842
http://dx.doi.org/10.2147/IJGM.S43192
work_keys_str_mv AT reitersuzanne barrierstoeffectivetreatmentofvaginalatrophywithlocalestrogentherapy